"Mini Circular Rna Therapeutics And Vaccines And Methods Of Use Thereof" in Patent Application Approval Process (USPTO 20240299520).

A patent application has been filed for synthetic mini circular RNA constructs that can be used as vaccines. These constructs aim to address challenges with the stability and production of mRNA vaccines by offering improved biostability, smaller size, and the ability to activate innate immunity. The mini circular RNA vectors have the potential to produce a strong immune response and may be particularly useful in cancer treatment and infectious disease prevention. The patent application also includes methods for preparing and administering these circRNA vaccines. [Extracted from the article]